Top Story

Fixed-dose combination therapy outperforms prostaglandin alone in reducing diurnal IOP

March 6, 2015

CORONADO, Calif. — Fixed-dose combination therapy significantly reduced diurnal IOP in patients with ocular hypertension or open-angle glaucoma, according to a poster presented at the American Glaucoma Society meeting.

The multicenter randomized study included 88 patients who received brinzolamide 1%/brimonidine 0.2% fixed combination (BBFC) combined with a prostaglandin analogue and 94 patients who received vehicle combined with a prostaglandin analogue.

SECO 030515 Harrington wmv th Meeting News CoverageVideo

VIDEO: HR expert offers tips for preventing a lawsuit

March 6, 2015
ATLANTA – Shauna Harrington, SPHR, reviewed key human resource-related elements to keep things legal in the optometric practice. Here at SECO, she…
Meeting News Coverage

Custom sequence testing may accurately define glaucoma severity

March 6, 2015
CORONADO, Calif. — Custom sequence testing for relative afferent pupillary defect may objectively quantify disease severity compared with standard testing…
Meeting News Coverage

Optometrists transition from stage 1 to stage 2 meaningful use

March 5, 2015
ATLANTA – Many optometrists are concerned about meeting the requirements of stage 2 meaningful use, according to a speaker here at SECO.Zachary McCarty, OD, said…
seco 030515 McCarty wmv th Meeting News CoverageVideo

VIDEO: Most ODs must still attest for meaningful use stage 2

March 5, 2015
ATLANTA – Zachary McCarty, OD, detailed the differences between stage 1 and stage 2 meaningful use here at SECO. One objective that he said may be…
More News Headlines »
CME
Postoperative Inflammation and Pain

Postoperative Inflammation and Pain: Elimination of the Dynamic Duo to Improve Patient Outcomes

This activity is supported by an educational grant from Bausch + Lomb.

Cataract surgery has improved in both safety and outcomes in recent years. With advances in surgical techniques…
More »
Meeting News Coverage Video
seco 030515 McCarty wmv th

VIDEO: Most ODs must still attest for meaningful use stage 2

March 5, 2015
ATLANTA – Zachary McCarty, OD, detailed the differences between stage 1 and stage 2 meaningful use here at…
More »
morganatic-roan
morganatic-roan